Dirk Hendriks

Dirk Hendriks is the current SVP & CFO of TheirtoCarta and GeneCarta at CellCarta. Dirk was previously employed at the University of Antwerp.

Dirk Hendriks has a PhD in Fibrinolysis from the University of Antwerp. Dirk is also a clinical pathologist with a PharmD and PhD in Pharmaceutical Sciences and Clinical Pathology from the University of Antwerp.

Dirk Hendriks works with Mark Kockx - Chief Scientific Officer & Medical Director, Todd Chermak - Chief Regulatory & Government Affairs Officer, and Lorella Di Donato - COO, ImmuneCarta & ProteoCarta. Dirk Hendriks reports to Martin Leblanc, CEO.